# GoodRx Holdings, Inc.: overview

GDRX · Nasdaq · CIK 1809519 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gdrx.md) · [Financials](/companies/gdrx/financials.md) · [Filings](/companies/gdrx/filings.md) · [Insiders](/companies/gdrx/insiders.md)

Latest reported revenue: [$200.4m](/filings/0001809519-26-000152.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001809519-26-000152).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [195](/filings/0001809519-25-000143.md) | [199 d](/filings/0001809519-26-000031.md) | [203](/filings/0001809519-26-000111.md) | [203](/filings/0001809519-26-000152.md) | [196](/filings/0001809519-25-000143.md) | [195 d](/filings/0001809519-26-000031.md) | [194](/filings/0001809519-26-000111.md) | [200](/filings/0001809519-26-000152.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [10.5%](/filings/0001809519-25-000143.md) | [9.2% d](/filings/0001809519-26-000031.md) | [11.5%](/filings/0001809519-26-000111.md) | [13.2%](/filings/0001809519-26-000152.md) | [7.5%](/filings/0001809519-25-000143.md) | [11.6% d](/filings/0001809519-26-000031.md) | [7.2%](/filings/0001809519-26-000111.md) | [11.8%](/filings/0001809519-26-000152.md) |
| Net margin | % | [2.0%](/filings/0001809519-25-000143.md) | [3.4% d](/filings/0001809519-26-000031.md) | [5.4%](/filings/0001809519-26-000152.md) | [6.3%](/filings/0001809519-26-000152.md) | [0.6%](/filings/0001809519-25-000143.md) | [2.8% d](/filings/0001809519-26-000031.md) | [0.6%](/filings/0001809519-26-000152.md) | [4.3%](/filings/0001809519-26-000152.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001809519-25-000143.md) | not reported | [0.03](/filings/0001809519-26-000111.md) | [0.04](/filings/0001809519-26-000152.md) | [0.00](/filings/0001809519-25-000143.md) | not reported | [0.00](/filings/0001809519-26-000111.md) | [0.02](/filings/0001809519-26-000152.md) |
| Free cash flow | $m | [86.5 d](/filings/0001809519-25-000143.md) | [44.6 d](/filings/0001809519-26-000031.md) | [9.3](/filings/0001809519-26-000111.md) | [49.2 d](/filings/0001809519-26-000152.md) | [74.3 d](/filings/0001809519-25-000143.md) | [31.6 d](/filings/0001809519-26-000031.md) | [10.7](/filings/0001809519-26-000111.md) | [80.5 d](/filings/0001809519-26-000152.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [745](/filings/0001809519-24-000032.md) | [767](/filings/0001809519-25-000040.md) | [750](/filings/0001809519-26-000031.md) | [792](/filings/0001809519-26-000031.md) | [797](/filings/0001809519-26-000031.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [1.8%](/filings/0001809519-24-000032.md) | [0.2%](/filings/0001809519-25-000040.md) | [(3.6%)](/filings/0001809519-26-000031.md) | [8.3%](/filings/0001809519-26-000031.md) | [11.0%](/filings/0001809519-26-000031.md) |
| Net margin | % | [(3.4%)](/filings/0001809519-24-000032.md) | [(4.3%)](/filings/0001809519-25-000040.md) | [(1.2%)](/filings/0001809519-26-000031.md) | [2.1%](/filings/0001809519-26-000031.md) | [3.8%](/filings/0001809519-26-000031.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001809519-24-000032.md) | [(0.08)](/filings/0001809519-25-000040.md) | [(0.02)](/filings/0001809519-26-000031.md) | [0.04](/filings/0001809519-26-000031.md) | [0.09](/filings/0001809519-26-000031.md) |
| Free cash flow | $m | [174](/filings/0001809519-24-000032.md) | [143](/filings/0001809519-25-000040.md) | [137](/filings/0001809519-26-000031.md) | [183](/filings/0001809519-26-000031.md) | [164](/filings/0001809519-26-000031.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gdrx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Francisco Partners Management, LP](/funds/1197853.md) | 2026-06-30 | $173.0m | 60,078,184 |  | Unchanged |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $13.7m | 4,746,330 |  | Added +290,570 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $11.8m | 4,086,521 |  | Reduced −174,995 |
| [Silver Lake Group, L.L.C.](/funds/1418226.md) | 2026-06-30 | $10.2m | 3,532,276 |  | Unchanged |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $9.3m | 3,245,738 |  | Reduced −14,000 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $9.2m | 3,208,264 |  | Reduced −154,600 |
| [Petrus Trust Company, LTA](/funds/1473429.md) | 2026-06-30 | $8.9m | 3,098,559 |  | Unchanged |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $7.4m | 2,560,229 |  | Added +109,088 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $6.7m | 2,326,080 |  | Added +523,735 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $6.7m | 2,313,184 |  | Added +1,665,363 |

## Recent filings

[All 572 filings](/companies/gdrx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-26 | 21:24 ET | [SCHEDULE 13D/A](/filings/0001193125-26-369290.md) | Ownership report, active investor, amended | 0001193125-26-369290 |
| 2026-08-05 | 16:09 ET | [8-K](/filings/0001809519-26-000153.md) | 5.02 Departure or appointment of officers or directors | 0001809519-26-000153 |
| 2026-08-05 | 16:09 ET | [10-Q](/filings/0001809519-26-000152.md) | Quarterly report, period 2026-06-30 | 0001809519-26-000152 |
| 2026-08-05 | 16:07 ET | [8-K](/filings/0001809519-26-000151.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001809519-26-000151 |
| 2026-06-18 | 16:19 ET | [8-K](/filings/0001809519-26-000133.md) | 5.07 Shareholder vote results | 0001809519-26-000133 |
| 2026-05-06 | 16:15 ET | [10-Q](/filings/0001809519-26-000111.md) | Quarterly report, period 2026-03-31 | 0001809519-26-000111 |
| 2026-05-06 | 16:13 ET | [8-K](/filings/0001809519-26-000110.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001809519-26-000110 |
| 2026-04-29 | 16:14 ET | [DEF 14A](/filings/0001809519-26-000091.md) | Proxy statement, period 2025-12-31 | 0001809519-26-000091 |
| 2026-04-24 | 16:29 ET | [8-K](/filings/0001809519-26-000080.md) | 5.02 Departure or appointment of officers or directors | 0001809519-26-000080 |
| 2026-04-03 | 16:09 ET | [8-K](/filings/0001809519-26-000071.md) | 5.02 Departure or appointment of officers or directors | 0001809519-26-000071 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001809519-26-000031.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/6a3d0668-3c0f-41d0-8576-da7d4dae6f51)

## About the filer

- CIK: 1809519
- Tickers: GDRX
- Exchange: Nasdaq
- SIC code: 7374 Services-Computer Processing & Data Preparation
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:00 ET. No prices; not investment advice.